SCHEMBL2500243

SCHEMBL2500243

C/C(=C\c1cccc(Cl)c1)C(=O)O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 4/20 0.63
KMT2A Q03164 3/20 0.55
MEN1 O00255 2/20 0.55
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
KDM4E B2RXH2 2/20 0.50
ALDH1A1 P00352 2/20 0.50
FBP1 P09467 1/20 0.50
POLB P06746 1/20 0.50
PKM P14618 1/20 0.50
MAOB P27338 3/20 0.49
APEX1 P27695 3/20 0.47
LMNA P02545 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
SLC9A1 P19634 1/20 0.46
SLC9A3 P48764 1/20 0.46
SLC9A2 Q9UBY0 1/20 0.46
TBXAS1 P24557 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2500244 1.00 AKR1C3 (0.63) AKR1C3KMT2AMEN1CYP1A2CYP2C9
SCHEMBL8746678 0.87 AKR1C3 (0.76) AKR1C3KMT2AMEN1KDM4EALDH1A1
SCHEMBL8746676 0.87 AKR1C3 (0.76) AKR1C3KMT2AMEN1KDM4EALDH1A1
SCHEMBL9476285 0.83 AKR1C3 (0.51) AKR1C3KMT2AMEN1CYP1A2CYP2C9
SCHEMBL9476279 0.83 AKR1C3 (0.51) AKR1C3KMT2AMEN1CYP1A2CYP2C9
SCHEMBL11246694 0.81 CYP1A2 (0.55) AKR1C3KMT2AMEN1CYP1A2CYP2C9
SCHEMBL10744557 0.81 AKR1C3 (0.55) AKR1C3KMT2AMEN1CYP2C9APEX1
SCHEMBL10744558 0.81 AKR1C3 (0.55) AKR1C3KMT2AMEN1CYP2C9APEX1
SCHEMBL394183 0.80 AKR1C3 (0.66) AKR1C3KMT2AMEN1ALDH1A1MAOB
SCHEMBL11547520 0.80 GLO1 (0.57) AKR1C3KMT2AMEN1CYP1A2CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110590529-A Preparation method of 1-aryl-2-acetone compound 浙江医药高等专科学校 2019-12-20 CN disclosed
EP-2693878-B1 SUBSTITUTED (3R,4R)-4-CYAN-3,4-DIPHENYLBUTANOATES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS BAYER IP GMBH (DE) 2018-06-27 EP disclosed
EP-2693878-A1 SUBSTITUTED (3R,4R)-4-CYAN-3,4-DIPHENYLBUTANOATES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS Bayer Intellectual Property GmbH (DE) 2014-02-12 EP disclosed
WO-2012126765-A1 SUBSTITUTED (3R,4R)-4-CYAN-3,4-DIPHENYLBUTANOATES, METHOD FOR THE PRODUCTION THEREOF AND USE THEREOF AS HERBICIDES AND PLANT GROWTH REGULATORS BAYER CROPSCIENCE AG (DE) 2012-09-27 WO disclosed
US-8030495-B2 Cyclopropyl pyrrolidine orexin receptor antagonists MERCK SHARP & DOHME CORP. 2011-10-04 US disclosed
EP-1091958-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2001-04-18 EP disclosed
WO-2000001692-A1 SALTS OF PAROXETINE SMITHKLINE BEECHAM PLC (GB) 2000-01-13 WO disclosed